Answer
Tisotumab vedotin could harm an unborn baby, including causing structural malformations, based on its mechanism and animal studies; no human pregnancy data are available, and it should not be used during pregnancy unless the woman's clinical condition requires it.
Sources for this answer
- TivdakGenmab A/S · emc · SmPC §4.6 Fertility, pregnancy and lactation · Version 1Document updated
Sources checked